• Company founder Eugen Münch and Asklepios pool their combined shareholding totaling almost 50% of RHÖN-KLINIKUM AG in a joint venture
• Announcement of takeover offer by Asklepios to all remaining shareholders of RHÖN-KLINIKUM AG with a cash offer price of € 18.00 per RHÖN-share
• Following completion of the transaction, the two partners aim to acquire the majority of voting rights in RHÖN-KLINIKUM AG
• Eugen Münch, founder and Chairman of the Supervisory Board of RHÖN-KLINIKUM AG: “We are joining forces with the shared goal of realizing our vision for healthcare in Germany under the umbrella of an Asklepios/ RHÖN group”
• Dr. Bernard große Broermann, founder and sole shareholder of Asklepios: “Today’s agreement marks a milestone for the future of healthcare in Germany”
